Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 228, Issue 6
Volume 228, Issue 6
15 September 2023
ISSN 0022-1899
EISSN 1537-6613

Volume 228, Issue 6, 15 September 2023

Editorial Commentary

Daniel S Fierer and Janke Schinkel
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 657–661, https://doi.org/10.1093/infdis/jiad265

Major Articles and Brief Reports

Viral Disease Pathogenesis

Adelina Artenie and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 662–673, https://doi.org/10.1093/infdis/jiad169

Modelling projects that HCV incidence will decrease by ≥80% over 2015–2030 (thus, achieving the WHO elimination target) among men who have sex with men and who inject drugs in San Francisco, largely due to high HCV testing and treatment.

Laura Andrea Barrero Guevara and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 674–683, https://doi.org/10.1093/infdis/jiad244

The spatial variability in varicella seasonality across the tropical climates of Colombia may be explained by differences in the seasonal patterns of humidity across municipalities. This has implications for epidemic preparedness and vaccine program evaluations in tropical countries.

Amiran Gamkrelidze and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 684–693, https://doi.org/10.1093/infdis/jiad064

Results of a 2021 nationwide serosurvey in Georgia indicate the country has reduced the prevalence of hepatitis C virus infection from 5.4% to 1.8% among adults since initiating a national hepatitis C elimination program in 2015, a reduction of 67%.

Shuang Lou and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 694–703, https://doi.org/10.1093/infdis/jiad065

By activating the JAK-STAT pathway, alpha kinase 1 (ALPK1) exerts anti-hepatitis B virus effects in hepatocytes. Furthermore, the ALPK1 P660L variant predicts response to pegylated interferon α therapy in hepatitis B e antigen-positive patients with chronic hepatitis B.

Carson L Smith and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 704–714, https://doi.org/10.1093/infdis/jiad071

We find that standard and adjuvanted influenza vaccines both induce increases in humoral and cellular immunity that contract to baseline by D180. In the 2016–2017 influenza season, the primary difference between vaccines was humoral antineuraminidase immunity to A/H3N2.

Covid-2019 Disease Pathogenesis

Xin Xia and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 715–722, https://doi.org/10.1093/infdis/jiad134

Vaccination with the orally aerosolised Ad5-nCoV could result in some spillage of the vaccine vector viral particles in the environment. However, improvement of the vaccine nebulizer could reduce the potential risk of viral particles exposure associated with the vaccination.

Maria Rebelo and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 723–733, https://doi.org/10.1093/infdis/jiad135

We show that NL-CVX1, a de novo human angiotensin-converting enzyme 2 protein decoy that blocks viral cell invasion, prevents severe disease after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in mice and may constitute a potent anti–SARS-CoV-2 treatment.

Louis Fries and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 734–741, https://doi.org/10.1093/infdis/jiad163

Primary series of NVX-CoV2373 vaccine with Matrix-M adjuvant induces polyfunctional CD4+ T-cell responses of balanced to moderately Th1-biased phenotype. Essentially equivalent cytokine production by vaccinee cells can be stimulated by spike proteins of ancestral or multiple variant sequences.

HIV/AIDs

Johannes M Schwenke and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 742–750, https://doi.org/10.1093/infdis/jiad179

An individual polygenic risk score was associated with osteoporosis in people living with HIV. The genetic effect was robust, as it persisted after multivariable adjustment for established traditional and HIV-related osteoporosis risk factors, including tenofovir disoproxil fumarate and boosted protease inhibitor exposure.

Sharmila Thippabhotla and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 751–758, https://doi.org/10.1093/infdis/jiad180

This study examined differences in RSFC in persons with and without HIV. Analysis showed RSFC was not affected by HIV status. Within persons with HIV no differences in RSFC were seen with regards to detectable viral load or cognitive impairment.

Parasites

Nadege Nziza and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 759–768, https://doi.org/10.1093/infdis/jiad115

This study highlights age-related evolution of malaria-specific antibody response and shows the natural evolution of functional humoral immunity to Plasmodium falciparum with age. Additionally, these data implicate specific antibody Fc-effector profiles in the control of malaria-associated disease in children.

Jill M C Hakim and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 769–776, https://doi.org/10.1093/infdis/jiad125

Amplicon sequencing of congenital chagas infection reveals complex infection in infants, suggesting that congenital infection is the result of multiple inoculating parasite clones.

Bacterial Disease Pathogenesis

Sivaprakash Ramalingam and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 777–782, https://doi.org/10.1093/infdis/jiad141

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by GBA gene mutations, which result in macrophage dysfunction. CRISPR correction of L444P GBA mutation in hiPSCs restores normal function to Gaucher macrophages and increases their susceptibility to Mycobacterium tuberculosis.

Sarah E Brown and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 783–791, https://doi.org/10.1093/infdis/jiad142

A secondary analysis utilizing a large, observational cohort of reproductive-age women revealed 48% of untreated urogenital chlamydia visits spontaneously cleared within the next 12 weeks. Amsel- and Nugent-defined bacterial vaginosis were associated with greater odds of persistence versus spontaneous clearance.

Yingxian Tang and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 792–799, https://doi.org/10.1093/infdis/jiad258

High-level antimicrobial resistance profiling of isolates from China in 2021 revealed sustained transmission of the penA-60.001 Neisseria gonorrhoeae clinical isolates, which might threaten further ceftriaxone treatment effectiveness.

Review

Ping Zheng and others
The Journal of Infectious Diseases, Volume 228, Issue 6, 15 September 2023, Pages 800–809, https://doi.org/10.1093/infdis/jiad253

Staphylococcus aureus is a dangerous human pathogen and humanized mice can overcome various limitations of traditional mice to better translate in vivo findings to humans, and are thus a promising mouse model.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close